SLC23A2 and ischemia: Here, the results-SVCT2 overexpression with AA treatment significantly reduced infarct volume in the present research-possibly give an answer why AA is a premature treatment for stroke is that the low expression of SVCT2 post-ischemia, which strengthens uptake of AA, blocks the AA intake to protect neural cells loss after brain injury.